Carson Wealth (CWM LLC)’s Skye Bioscience SKYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-90
Closed 5701
2025
Q3
$0 Sell
90
-2,396
-96% -$9.05K ﹤0.01% 5604
2025
Q2
$10K Buy
2,486
+2,203
+778% +$4.56K ﹤0.01% 4323
2025
Q1
$0 Buy
283
+280
+9,333% +$764 ﹤0.01% 5237
2024
Q4
$0 Sell
3
-26
-90% -$109 ﹤0.01% 5214
2024
Q3
$0 Buy
+29
New +$163 ﹤0.01% 5214

Other funds holding SKYE

Carson Wealth (CWM LLC)'s SKYE Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of Skye Bioscience (SKYE) in Q4 2025, closing a stake of 90 shares.

Carson Wealth (CWM LLC) first reported a position in SKYE in Q3 2024 and held it in 5 quarters. The position peaked at $10K in Q2 2025. 50 funds tracked by Wall St. Rank hold SKYE as of Q4 2025.

  • Carson Wealth (CWM LLC) reported no remaining Skye Bioscience position as of Q4 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 90 Skye Bioscience shares in Q4 2025.
  • Carson Wealth (CWM LLC) first reported a position in Skye Bioscience in Q3 2024 and held it in 5 quarters.
  • Carson Wealth (CWM LLC)'s Skye Bioscience position peaked at $10K in Q2 2025.
  • 50 funds tracked by Wall St. Rank held Skye Bioscience as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.